Due to the intriguing findings for ER modulators 27-HC and 25-HC with respect to breast cancer prognosis, we aimed to extend this line of enquiry by investigating a range of other oxysterols representing different pathways of cholesterol metabolism among women with a breast cancer diagnosis and with mechanisms beyond ER signaling. This evidence concerns the gene ESR1 and breast carcinoma.